#BenchToBedside

Tara Lin, MD, director of The University of Kansas Cancer Center's Acute Leukemia Program and medical director for KU Cancer Center's Clinical Trials Office (CTO). With September being Blood Cancer Awareness month, an ideal time to call attention to advances in leukemia care, the conversation will focus specifically on acute myeloid leukemia, or #AML.

[@paddywhack9261]

I chose not to have a Bone Marrow Transplant. i'm 76, nHL from Agent Orange exposure 1968, refractory to Rituxan-based therapy after 64 infusions [2011-2017] and 2-1/2 months of oral Zydelig [3/2018-6/2018]. Dx "in clinical remission" 8/2018. Dx 11/2018 with MDS/anemia. Currently on w&w, quarterly CBCs, vitamins and mineral supplements per Oncologist, still following a 5-decade lacto-pescatarian diet; no transfusions. Taking my chances with AML.

[@reneebielling1069]

Is City of Hope in Duarte California an Academic Medical Center like dr. Lin spoke about?